Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-072024
Filing Date
2025-05-15
Accepted
2025-05-15 08:15:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8146
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 7647
  Complete submission text file 0000950170-25-072024.txt   20699
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 11 HUGHES IRVINE CA 92618
Business Address 11 HUGHES IRVINE CA 92618 949-427-7785
Beta Bionics, Inc. (Subject) CIK: 0001674632 (see all company filings)

EIN.: 475386878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94834 | Film No.: 25948866
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)